{"id":4074,"date":"2025-07-11T11:35:06","date_gmt":"2025-07-11T08:35:06","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=4074"},"modified":"2025-07-11T13:23:35","modified_gmt":"2025-07-11T10:23:35","slug":"belief-biomed-bbm-d101-gene-therapy-phase-1-2-clinical-trial-nct07058662","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/tr\/belief-biomed-bbm-d101-gene-therapy-phase-1-2-clinical-trial-nct07058662\/","title":{"rendered":"BBM-D101 Gen Terapisi Faz 1\/2 Klinik Denemesi Ba\u015fl\u0131yor"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Merkezi \u00c7in'de bulunan Belief BioMed (BBM), gen terapisi \u00fcr\u00fcnlerinin geli\u015ftirilmesi, \u00fcretimi ve klinik uygulamas\u0131n\u0131 entegre eden k\u00fcresel bir yenilik\u00e7i biyoteknoloji \u015firketidir. ClinicalTrials.gov'da NCT07058662 kimlik numaras\u0131yla yay\u0131nlanan sayfada, Duchenne Musk\u00fcler Distrofi i\u00e7in geli\u015ftirilen BBM-D101 gen terapisinin faz 1\/2 denemelerinin ba\u015flat\u0131laca\u011f\u0131 duyurulmu\u015ftur.<\/p>\n\n\n\n<div class=\"wp-block-rank-math-toc-block\" id=\"rank-math-toc\"><h2>\u0130\u00e7indekiler<\/h2><nav><ul><li><a href=\"#bbm-d-101-gene-therapy-phase-1-2-clinical-trial\">BBM-D101 Gen Terapisi Faz 1\/2 Klinik \u00c7al\u0131\u015fmas\u0131<\/a><\/li><li><a href=\"#bbm-d-101-clinical-trial-nct-07058662\">BBM-D101 Klinik Ara\u015ft\u0131rmas\u0131 \u2013 NCT07058662<\/a><\/li><li><a href=\"#bbm-d-101-phase-1-2-participation-criteria\">BBM-D101 Faz 1\/2 Kat\u0131l\u0131m Kriterleri<\/a><\/li><li><a href=\"#how-can-i-contact-with-belief-bio-med\">Belief BioMed ile Nas\u0131l \u0130leti\u015fime Ge\u00e7ebilirim?<\/a><\/li><\/ul><\/nav><\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"bbm-d-101-gene-therapy-phase-1-2-clinical-trial\">BBM-D101 Gen Terapisi Faz 1\/2 Klinik \u00c7al\u0131\u015fmas\u0131<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">\u00c7al\u0131\u015fman\u0131n amac\u0131, BBM-D101&#039;in Duchenne Musk\u00fcler Distrofisi olan kat\u0131l\u0131mc\u0131lar\u0131n tedavisinde g\u00fcvenli\u011fini, tolere edilebilirli\u011fini ve etkinli\u011fini de\u011ferlendirmektir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">BBM-D101, DMD tedavisinde kullan\u0131lmak \u00fczere tasarlanm\u0131\u015f AAV iletimli terap\u00f6tik protein gen kasetine dayanan bir gen ekleme tedavisidir. Terap\u00f6tik protein, distrofinle ili\u015fkili protein kompleksini etkileyerek kas distrofisini \u00f6nleyebilir ve kas\u0131n i\u015flevini kurtarabilir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"bbm-d-101-clinical-trial-nct-07058662\">BBM-D101 Klinik Ara\u015ft\u0131rmas\u0131 \u2013 NCT07058662<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u00c7al\u0131\u015fma Ba\u015flang\u0131c\u0131 (Tahmini)<\/strong>: 2025-06-30<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Birincil Tamamlanma (Tahmini)<\/strong>: 2027-06-30<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u00c7al\u0131\u015fman\u0131n Tamamlanmas\u0131 (Tahmini)<\/strong>: 2031-06-30<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Kat\u0131l\u0131mc\u0131 Say\u0131s\u0131 (Tahmini)<\/strong>: 9 (Erkek)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Konumlar<\/strong>: \u00c7in<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u00c7al\u0131\u015fmaya Uygun Ya\u015flar<\/strong>: 4 Ya\u015f - 9 Ya\u015f (\u00c7ocuk)<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"bbm-d-101-phase-1-2-participation-criteria\">BBM-D101 Faz 1\/2 Kat\u0131l\u0131m Kriterleri<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Uygun olabilmek i\u00e7in ki\u015filerin dahil olma gerekliliklerini yerine getirmeleri gerekir. Bir ki\u015finin ba\u015fka bir rahats\u0131zl\u0131\u011f\u0131 varsa veya gen terapisi almas\u0131n\u0131 engelleyebilecek bir tedavi g\u00f6r\u00fcyorsa, kat\u0131l\u0131m g\u00f6steremeyebilir. Dahil olma ve hari\u00e7 tutma kriterlerinin tamam\u0131na bu \u00e7al\u0131\u015fma ba\u011flant\u0131s\u0131na t\u0131klayarak ula\u015f\u0131labilir \u2013 <a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07058662\" target=\"_blank\" rel=\"noreferrer noopener\">NCT07058662<\/a> \u2013.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"how-can-i-contact-with-belief-bio-med\">Belief BioMed ile Nas\u0131l \u0130leti\u015fime Ge\u00e7ebilirim?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u0130sim<\/strong>: Hanyang Hu<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Telefon Numaras\u0131<\/strong>: +86-021-33588288<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>E-posta<\/strong>: huhanyang@beliefbiomed.com<\/p>","protected":false},"excerpt":{"rendered":"<p>Belief BioMed (BBM), headquartered in China, is a global innovative biotechnology company integrating the development, manufacturing and clinical application of gene therapy products. It was announced on the page published on ClinicalTrials.gov with the ID NCT07058662 that the phase 1\/2 trials of BBM-D101 gene therapy developed for Duchenne Muscular Dystrophy will be initiated. BBM-D101 Gene [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4082,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[199,197,123,137,61,389],"class_list":["post-4074","post","type-post","status-publish","format-standard","has-post-thumbnail","category-research","tag-bbm-d101","tag-belief-biomed","tag-china","tag-clinical-trial","tag-gene-therapy","tag-nct07058662"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/4074","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/comments?post=4074"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/4074\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media\/4082"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media?parent=4074"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/categories?post=4074"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/tags?post=4074"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}